Clinical Trial Update: LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating LY231514 plus gemcitabine for metastatic breast cancer in women. The trial was s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• LY231514 (LY231514)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED